VIR
Income statement / Annual
Last year (2023), Vir Biotechnology, Inc.'s total revenue was $86.18 M,
a decrease of 94.55% from the previous year.
In 2023, Vir Biotechnology, Inc.'s net income was -$615.06 M.
See Vir Biotechnology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$86.18 M
|
$1.58 B
|
$1.09 B
|
$67.25 M
|
$711,000.00
|
$868,000.00
|
$149,000.00
|
| Cost of Revenue |
$2.77 M |
$146.32 M |
$65.87 M |
$301.58 M |
$148.47 M |
$100.23 M |
$62.51 M |
| Gross Profit |
$83.42 M |
$1.43 B |
$1.02 B |
-$234.33 M |
-$147.76 M |
-$99.36 M |
-$62.36 M |
| Gross Profit Ratio |
0.97 |
0.91 |
0.94 |
-3.48 |
-207.82 |
-114.47 |
-418.54 |
| Research and Development
Expenses |
$589.67 M
|
$474.65 M
|
$448.01 M
|
$302.41 M
|
$148.47 M
|
$100.23 M
|
$62.51 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$70.94 M
|
$37.60 M
|
$29.13 M
|
$21.69 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$174.05 M
|
$161.76 M
|
$160.79 M
|
$70.94 M
|
$37.60 M
|
$29.13 M
|
$21.69 M
|
| Other Expenses |
$0.00 |
-$35.33 M |
-$8.35 M |
-$9.12 M |
-$7.38 M |
-$212,000.00 |
$83,000.00 |
| Operating Expenses |
$767.72 M |
$601.09 M |
$600.45 M |
$364.23 M |
$178.69 M |
$119.56 M |
$81.65 M |
| Cost And Expenses |
$770.49 M |
$747.40 M |
$666.32 M |
$364.23 M |
$178.69 M |
$119.56 M |
$81.65 M |
| Interest Income |
$86.99 M |
$28.09 M |
$439,000.00 |
$2.84 M |
$8.51 M |
$2.54 M |
$638,000.00 |
| Interest Expense |
$0.00 |
$183.15 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$19.45 M
|
$15.49 M
|
$11.98 M
|
$8.81 M
|
$4.52 M
|
$2.76 M
|
$432,000.00
|
| EBITDA |
-$664.85 M
|
$833.07 M
|
$420.75 M
|
-$289.80 M
|
-$173.46 M
|
-$115.94 M
|
-$81.07 M
|
| EBITDA Ratio |
-7.71 |
0.6 |
0.26 |
-4.42 |
-250.32 |
-133.57 |
-544.06 |
| Operating Income Ratio
|
-7.94
|
0.53
|
0.25
|
-4.42
|
-250.32
|
-136.74
|
-546.96
|
| Total Other
Income/Expenses Net |
$56.11 M
|
-$78.79 M
|
$129.05 M
|
-$1.63 M
|
$3.45 M
|
$2.33 M
|
$721,000.00
|
| Income Before Tax |
-$628.19 M |
$754.28 M |
$549.80 M |
-$298.61 M |
-$174.53 M |
-$116.36 M |
-$80.78 M |
| Income Before Tax Ratio
|
-7.29
|
0.48
|
0.51
|
-4.44
|
-245.47
|
-134.06
|
-542.12
|
| Income Tax Expense |
-$13.08 M |
$238.44 M |
$21.22 M |
$54,000.00 |
$154,000.00 |
-$480,000.00 |
-$10.92 M |
| Net Income |
-$615.06 M |
$515.84 M |
$528.58 M |
-$298.67 M |
-$174.68 M |
-$115.88 M |
-$69.85 M |
| Net Income Ratio |
-7.14 |
0.33 |
0.49 |
-4.44 |
-245.69 |
-133.51 |
-468.81 |
| EPS |
-4.59 |
3.89 |
4.07 |
-2.51 |
-1.62 |
-1.2 |
-0.72 |
| EPS Diluted |
-4.59 |
3.83 |
3.96 |
-2.51 |
-1.62 |
-1.2 |
-0.72 |
| Weighted Average Shares
Out |
$134.13 M
|
$132.61 M
|
$129.88 M
|
$119.16 M
|
$107.65 M
|
$96.91 M
|
$96.91 M
|
| Weighted Average Shares
Out Diluted |
$134.13 M
|
$134.81 M
|
$133.44 M
|
$119.16 M
|
$107.65 M
|
$96.91 M
|
$96.91 M
|
| Link |
|
|
|
|
|
|
|
